2022年業績

• Hisashi Saji, Morihito Okada, Masahiro Tsuboi, Ryu Nakajima, Kenji Suzuki, Keiju Aokage, Tadashi Aoki, Jiro Okami, Ichiro Yoshino, Hiroyuki Ito, Norihito Okumura, Masafumi Yamaguchi, Norihiko Ikeda, Masashi Wakabayashi, Kenichi Nakamura, Haruhiko Fukuda, Shinichiro Nakamura, Tetsuya Mitsudomi, Shun-Ichi Watanabe, Hisao Asamura, on behalf of the West Japan Oncology Group and Japan Clinical Oncology Group. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet. 399: 1607-1617, 2022
• Patrick M Forde, Jonathan Spicer, Shun Lu, Mariano Provencio, Tetsuya Mitsudomi, Mark M Awad, Enriqueta Felip, Stephen R Broderick, Julie R Brahmer, Scott J Swanson, Keith Kerr, Changli Wang, Tudor-Eliade Ciuleanu, Gene B Saylors, Fumihiro Tanaka, Hiroyuki Ito, Ke-Neng Chen, Moishe Liberman, Everett E Vokes, Janis M Taube, Cecile Dorange, Junliang Cai, Joseph Fiore, Anthony Jarkowski, David Balli, Mark Sausen, Dimple Pandya, Christophe Y Calvet, Nicolas Girard, CheckMate 816 Investigators. Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer. New England Journal of Medicine. 386(21): 1973-1985, 2022
• Yuki Matsumura, Hikaru Yamaguchi, Kazuyuki Watanabe, Hiroyuki Suzuki. Lateral- or prone-position video-assisted thoracic surgery for dumbbell-type posterior mediastinal tumors: pros and cons. Indian Journal of Thoracic and Cardiovascular Surgery. 38(4): 430-433, 2022
• Yuki Matsumura, Mitsuro Fukuhara, Hayato Tanabe, Hikaru Yamaguchi, Hironori Takagi, Yuki Ozaki, Satoshi Muto, Naoyuki Okabe, Yutaka Shio, Hiroyuki Suzuki. Thoracoscopic resection of posterior mediastinal paraganglioma: perioperative management and surgical tips. Journal of Cardiothoracic Surgery. 17: 143, 2022
• Masayuki Watanabe, Yuki Matsumura, Hikaru Yamaguchi, Hayato Mine, Hironori Takagi, Yuki Ozaki, Mitsuro Fukuhara, Satoshi Muto, Naoyuki Okabe, Yutaka Shio, Hiroyuki Suzuki. Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report. Thoracic cancer. 13: 2817-2822, 2022
• Sho Inomata, Yuki Matsumura, Yasuyuki Kobayashi, Hikaru Yamaguchi, Masayuki Watanabe, Yuki Ozaki, Satoshi Muto, Naoyuki Okabe, Yutaka Shio, Hiroyuki Suzuki. Lung adenocarcinoma coexisting with diffuse idiopathic pulmonary neuroendocrine cell hyperplasia manifesting as multiple pulmonary nodules: A case report. Thoracic cancer. 13: 3076-3079, 2022
• Hironori Takagi, Yuki Matsumura, Mitsuro Fukuhara, Sho Inomata, Hikaru Yamaguchi, Masayuki Watanabe, Yuki Ozaki, Satoshi Muto, Naoyuki Okabe, Yutaka Shio, Haruka Saito, Hayato Tanabe, Michio Shimabukuro, Hiroyuki Suzuki. Ectopic adrenocorticotropic hormone-secreting carcinoid with solitary cryptococcosis in the lungs. Cancer reports. 5: e1731, 2022
• Mie Kotake, Hisao Imai, Kyoichi Kaira, Hideki Endoh, Yutaka Yamada, Takayuki Kaburagi, Moriyuki Kiyoshima, Tomohide Sugiyama, Yoichi Nakamura, Takashi Kasai, Haruhisa Matsuguma, Hiroyuki Minemura, Kenya Kanazawa, Hiroyuki Suzuki, Atsushi Fujita, Koichi Minato. Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma. Chemotherapy. 67: 142-151, 2022
• Mitsuro Fukuhara, Satoshi Muto, Sho Inomata, Hikaru Yamaguchi, Hayato Mine, Hironori Takagi, Yuki Ozaki, Masayuki Watanabe, Takuya Inoue, Takumi Yamaura, Naoyuki Okabe, Yuki Matsumura, Takeo Hasegawa, Jun Osugi, Mika Hoshino, Mitsunori Higuchi, Yutaka Shio, Hiroyuki Suzuki. The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: a single-center, retrospective study. Cancer Immunology, Immunotherapy. 71(5): 1129-1137, 2022
• 鈴木弘行, 猪俣頌, 山口光, 峯勇人, 髙木玄教, 尾崎有紀, 渡部晶之, 井上卓哉, 福原光朗, 山浦匠, 武藤哲史, 岡部直行, 松村勇輝, 長谷川剛生, 大杉純, 星野実加, 樋口光徳, 塩　　豊. 特別企画(7)　≪外科学再興特別企画≫癌に対する免疫治療 New Era 6. 癌に対する複合免疫療法の新展開〜外科医でなければできないこと〜. 日本外科学会雑誌. 123(1): 95-97, 2022
• 髙木玄教, 武藤哲史, 福原光朗, 猪俣頌, 山口光, 渡部晶之, 尾崎有紀, 岡部直行, 松村勇輝, 塩豊, 鈴木弘行. 術中に使用したソフト凝固が原因と考えられた遅発性の気管支穿孔の1例. 気管支学. 44(1): 44-49, 2022
• 倉富勇一郎, 鈴木弘行. シンポジウム2「Immuno-Oncology 時代のがん治療」司会者のまとめ. 日本気管食道科学会会報. 73(2): 77-78, 2022
• 山口光, 武藤哲史, 猪俣頌, 渡部晶之, 尾崎有紀, 岡部直行, 松村勇輝, 塩豊, 鈴木弘行. 経気管支生検ののち自然消退したが，4ヵ月後に再増大を認めた肺扁平上皮癌の1例. 肺癌. 62(2): 103-106, 2022
• 武藤哲史, 鈴木弘行. 連載◆未来の専門医を育てる！福島県立医科大学呼吸器外科での学生・若手医師への教育. 胸部外科. 75(7): 534-536, 2022
• 鈴木弘行. Current Organ Topics: Thorax/Lung and Mediastinum, Pleura: Cancer 肺癌　肺癌診療における最新のトピックス2022 総括. 癌と化学療法. 49(8): 835-836, 2022
• 武藤哲史, 猪俣頌, 山口光, 峯勇人, 髙木玄教, 渡部晶之, 尾崎有紀, 井上卓哉, 山浦匠, 福原光朗, 岡部直行, 松村勇輝, 長谷川剛生, 大杉純, 星野実加, 樋口光徳, 塩豊, 鈴木弘行. 肺癌におけるβ-cateninに注目した免疫チェックポイント阻害薬耐性メカニズムとその克服. 癌と化学療法. 49(9): 928-931, 2022
• 武藤哲史, 猪俣頌, 山口光, 峯勇人, 髙木玄教, 渡部晶之, 尾崎有紀, 井上卓哉, 山浦匠, 福原光朗, 岡部直行, 松村勇輝, 長谷川剛生, 大杉純, 星野実加, 樋口光徳, 塩豊, 鈴木弘行. 非小細胞肺癌でのβ-catenin発現と免疫チェックポイント阻害薬の治療効果. 癌と化学療法. 49(9): 947-949, 2022
• 尾崎有紀, 武藤哲史, 鈴木理, 鈴木弘行. CT で充実性結節を示しリンパ節転移を来していた微少浸潤性腺癌の1手術例. 肺癌. 62(5): 389-394, 2022
• 鈴木弘行. 特別企画 福島県近代医学教育150年顕彰記念シンポジウム総説 福島県立医科大学が目指すがん治療―地域に根ざした先進医療の実践―. 福島医学雑誌. 72(3): 109-113, 2022
• 鈴木弘行. 編集後記. 日本免疫治療学会誌. 10: 39, 2022